Literature DB >> 30948402

Successful clozapine rechallenge in a patient with suspected drug induced lupus.

Suraj Pathak1, Scott Cherry2, Samreen Samad3, Ambreen Aftab3.   

Abstract

Clozapine is the most effective treatment for patients with refractory schizophrenia. Clozapine is also associated with serious and potentially lethal side effects including drug induced lupus (DIL). There have been four previous published case reports describing clozapine inducing a lupus-like syndrome including one previous case where a clozapine rechallenge was attempted without success. This case report describes a successful clozapine rechallenge in a patient with suspected DIL. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs: psychiatry; psychiatry (drugs and medicines); schizophrenia; systemic lupus erythematosus

Mesh：

Substances：

Year:  2019        PMID： 30948402      PMCID： PMC6453414          DOI： 10.1136/bcr-2018-228574

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  8 in total

1.  Clozapine-induced lupus erythematosus.

Authors:  Joachim Wolf; Alexander Sartorius; Barbara Alm; Fritz A Henn
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

2.  Life-Threatening Lupus-Like Syndrome Associated With Clozapine.

Authors:  Nadica Buzina; Marija Eterović
Journal:  J Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.153

Review 3.  When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.

Authors:  Peter Manu; Deepak Sarpal; Owen Muir; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2011-11-22       Impact factor: 4.939

4.  Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.

Authors:  Louisa R Dunk; Linda J Annan; Christopher D Andrews
Journal:  Br J Psychiatry       Date:  2006-03       Impact factor: 9.319

5.  Acute severe adverse clozapine reaction resembling systemic lupus erythematosus.

Authors:  W A Wickert; N R Campbell; L Martin
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Clozapine-induced systemic lupus erythematosus.

Authors:  Abu Fanne Rami; Daniel Barkan; Dror Mevorach; Eran Leitersdorf; Yoseph Caraco
Journal:  Ann Pharmacother       Date:  2006-05-02       Impact factor: 3.154

8.  Contemporary treatment of systemic lupus erythematosus: an update for clinicians.

Authors:  Maame B Amissah-Arthur; Caroline Gordon
Journal:  Ther Adv Chronic Dis       Date:  2010-07       Impact factor: 5.091
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.